Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$183M |
| 3 |
Meta Platforms (Facebook)
META
|
+$179M |
| 4 |
PepsiCo
PEP
|
+$149M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$138M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$243M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$163M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$85.5M |
| 4 |
SFR
Starwood Waypoint Homes
SFR
|
+$45.3M |
| 5 |
BRCD
Brocade Communications Systems, Inc. NEW
BRCD
|
+$42.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.85% |
| 2 | Financials | 16.38% |
| 3 | Healthcare | 13.22% |
| 4 | Industrials | 10.47% |
| 5 | Consumer Discretionary | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGNX
2376
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $3.61M | ﹤0.01% |
606,510
+3,416
| +0.6% | +$20.8K |
|
2377
Rhythm Pharmaceuticals
RYTM
$7.99B
| $3.6M | ﹤0.01% |
+123,795
| New | +$3.27M |
|
|
AFI
2378
DELISTED
Armstrong Flooring, Inc.
AFI
| $3.6M | ﹤0.01% |
212,569
-6,573
| -3% | -$107K |
|
|
PRTK
2379
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $3.59M | ﹤0.01% |
200,782
+5,151
| +3% | +$107K |
|
2380
First Community Bankshares
FCBC
$933M
| $3.58M | ﹤0.01% |
124,736
+644
| +0.5% | +$18.9K |
|
2381
Mesa Laboratories
MLAB
$633M
| $3.56M | ﹤0.01% |
28,679
+77
| +0.3% | +$10.8K |
|
2382
Atara Biotherapeutics
ATRA
$76.7M
| $3.56M | ﹤0.01% |
7,874
+190
| +2% | +$70.2K |
|
|
BRS
2383
DELISTED
Bristow Group, Inc.
BRS
| $3.56M | ﹤0.01% |
264,583
+11,179
| +4% | +$132K |
|
2384
NovoCure
NVCR
$2.02B
| $3.56M | ﹤0.01% |
176,000
+3,823
| +2% | +$73.6K |
|
|
AKCA
2385
DELISTED
Akcea Therapeutics Inc
AKCA
| $3.55M | ﹤0.01% |
204,540
+3,147
| +2% | +$61.7K |
|
2386
Collegium Pharmaceutical
COLL
$913M
| $3.54M | ﹤0.01% |
191,634
+14,589
| +8% | +$209K |
|
|
GLUU
2387
DELISTED
Glu Mobile Inc.
GLUU
| $3.54M | ﹤0.01% |
971,926
+22,206
| +2% | +$89.3K |
|
|
SHOE
2388
Shoe Station Group
SHOE
$415M
| $3.54M | ﹤0.01% |
264,450
-139,460
| -35% | -$1.62M |
|
|
DNI
2389
DELISTED
Dividend and Income Fund
DNI
| $3.52M | ﹤0.01% |
262,237
+29,071
| +12% | +$386K |
|
2390
Nicolet Bankshares
NIC
$3.73B
| $3.51M | ﹤0.01% |
64,095
+4,540
| +8% | +$262K |
|
|
BFX
2391
DELISTED
BowFlex Inc.
BFX
| $3.5M | ﹤0.01% |
262,546
+2,411
| +0.9% | +$34.9K |
|
|
ANCX
2392
DELISTED
Access National Corp
ANCX
| $3.5M | ﹤0.01% |
125,888
+824
| +0.7% | +$23.6K |
|
|
ASNA
2393
DELISTED
Ascena Retail Group, Inc.
ASNA
| $3.5M | ﹤0.01% |
74,473
+1,894
| +3% | +$79.8K |
|
2394
Cytokinetics
CYTK
$10.2B
| $3.49M | ﹤0.01% |
428,548
+6,813
| +2% | +$77.3K |
|
2395
Cato Corp
CATO
$66.7M
| $3.49M | ﹤0.01% |
219,077
-12,482
| -5% | -$181K |
|
2396
Spok Holdings
SPOK
$230M
| $3.49M | ﹤0.01% |
222,906
-41,854
| -16% | -$701K |
|
|
SNCR
2397
DELISTED
Synchronoss Technologies
SNCR
| $3.48M | ﹤0.01% |
43,325
+1,400
| +3% | +$135K |
|
2398
Zumiez
ZUMZ
$319M
| $3.48M | ﹤0.01% |
167,142
+4,885
| +3% | +$93.5K |
|
2399
Digimarc Corp
DMRC
$158M
| $3.47M | ﹤0.01% |
96,022
+1,538
| +2% | +$55.9K |
|
2400
Park-Ohio Holdings
PKOH
$718M
| $3.46M | ﹤0.01% |
75,410
+677
| +0.9% | +$30.3K |
|
Similar funds
Geode Capital Management's Q4 2017 Portfolio in Review
As of Q4 2017, Geode Capital Management held 4,142 positions worth $294B, up 8.7% from $271B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Geode Capital Management's Q4 2017 filing shows 98 new, 2,556 increased, 827 reduced and 120 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M. The largest sale was CR Bard Inc., an estimated $243M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 742,921 shares worth $39M.
- Geode Capital Management added most to Apple in Q4 2017, an estimated $227M increase.
- Geode Capital Management's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $23.7M.
- Geode Capital Management fully exited CR Bard Inc. in Q4 2017, selling an estimated $243M.
- Geode Capital Management's ten largest holdings make up 17% of its $294B portfolio in Q4 2017.
- Geode Capital Management opened 98 new positions and closed 120 in Q4 2017.
- Geode Capital Management's portfolio value rose 8.7% quarter-over-quarter to $294B.
Based on Geode Capital Management's 13F filing for Q4 2017, filed 13 Feb 2018.